CRISPR Therapeutics AG
Public company- Headquarters
- ZUG
- Industry
- Biotechnology
- Ticker
- CRSP
- CIK
- 0001674416
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOAndrew J. Silver | Oct 19, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Entera Bio Ltd.
Class II director appointed: Juan Camilo Arjona Ferreira, M.D.
- BioNTech SE
WARN notice: Gaithersburg, MD
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Executive appointment
CFO appointed: Andrew J. Silver
Andrew J. Silver was named Chief Financial Officer of CRISPR Therapeutics AG, effective October 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 19, 2026Role: Chief Financial Officer
- Executive departure
CFO departs: Raju Prasad, Ph.D.
Raju Prasad, Ph.D., Chief Financial Officer of CRISPR Therapeutics AG, resigns the role, effective October 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 19, 2026Role: Chief Financial Officer
Last verified Nov 8, 2026